401k Plan data: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN plan

INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 401k Plan overview

Plan Name	INOVIO PHARMACEUTICALS, INC. 401(K) PLAN
Plan identification number	001

INOVIO PHARMACEUTICALS, INC. 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) received services of leased employees, as defined in Code section 414(n), during the plan year.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

INOVIO PHARMACEUTICALS, INC. has sponsored the creation of one or more 401k plans.

Company Name: INOVIO PHARMACEUTICALS, INC.

Employer identification number (EIN): 330969592

NAIC Classification: 541700

Form 5500 Filing Information

Submission information for form 5500 for 401k plan INOVIO PHARMACEUTICALS, INC. 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 PETER KIES PETER KIES 2018-10-08
001 2016-01-01 PETER KIES
001 2015-01-01 PETER KIES 2016-07-06
001 2014-01-01 PETER KIES 2015-07-07 PETER KIES 2015-07-07
001 2013-01-01 PETER KIES 2014-09-22 PETER KIES 2014-09-22
001 2012-01-01 PETER KIES 2013-07-09 PETER KIES 2013-07-09
001 2011-01-01 PETER KIES 2012-07-31 PETER KIES 2012-07-31
001 2010-04-01 PETER KIES 2011-09-29

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01
001	2021-01-01
001	2020-01-01
001	2019-01-01
001	2018-01-01
001	2017-01-01	PETER KIES		PETER KIES	2018-10-08
001	2016-01-01	PETER KIES
001	2015-01-01	PETER KIES	2016-07-06
001	2014-01-01	PETER KIES	2015-07-07	PETER KIES	2015-07-07
001	2013-01-01	PETER KIES	2014-09-22	PETER KIES	2014-09-22
001	2012-01-01	PETER KIES	2013-07-09	PETER KIES	2013-07-09
001	2011-01-01	PETER KIES	2012-07-31	PETER KIES	2012-07-31
001	2010-04-01	PETER KIES	2011-09-29

Plan Statistics for INOVIO PHARMACEUTICALS, INC. 401(K) PLAN

401k plan membership statisitcs for INOVIO PHARMACEUTICALS, INC. 401(K) PLAN

Measure Date Value
2022: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 387
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 216
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 161
Total of all active and inactive participants 2022-01-01 377
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 377
Number of participants with account balances 2022-01-01 349
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 29
2021: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 338
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 275
Number of retired or separated participants receiving benefits 2021-01-01 1
Number of other retired or separated participants entitled to future benefits 2021-01-01 104
Total of all active and inactive participants 2021-01-01 380
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 380
Number of participants with account balances 2021-01-01 337
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 13
2020: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 294
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 229
Number of retired or separated participants receiving benefits 2020-01-01 1
Number of other retired or separated participants entitled to future benefits 2020-01-01 103
Total of all active and inactive participants 2020-01-01 333
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 333
Number of participants with account balances 2020-01-01 294
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 8
2019: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 318
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 172
Number of retired or separated participants receiving benefits 2019-01-01 1
Number of other retired or separated participants entitled to future benefits 2019-01-01 118
Total of all active and inactive participants 2019-01-01 291
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 291
Number of participants with account balances 2019-01-01 262
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 38
2018: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 294
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 266
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 47
Total of all active and inactive participants 2018-01-01 313
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 313
Number of participants with account balances 2018-01-01 253
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 25
2017: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 232
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 248
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 32
Total of all active and inactive participants 2017-01-01 280
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 280
Number of participants with account balances 2017-01-01 208
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 15
2016: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 414
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 199
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 21
Total of all active and inactive participants 2016-01-01 220
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 220
Number of participants with account balances 2016-01-01 161
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 14

Measure	Date	Value
2022: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	387
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	216
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	161
Total of all active and inactive participants	2022-01-01	377
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	377
Number of participants with account balances	2022-01-01	349
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	29
2021: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	338
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	275
Number of retired or separated participants receiving benefits	2021-01-01	1
Number of other retired or separated participants entitled to future benefits	2021-01-01	104
Total of all active and inactive participants	2021-01-01	380
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	380
Number of participants with account balances	2021-01-01	337
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	13
2020: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	294
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	229
Number of retired or separated participants receiving benefits	2020-01-01	1
Number of other retired or separated participants entitled to future benefits	2020-01-01	103
Total of all active and inactive participants	2020-01-01	333
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	333
Number of participants with account balances	2020-01-01	294
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	8
2019: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	318
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	172
Number of retired or separated participants receiving benefits	2019-01-01	1
Number of other retired or separated participants entitled to future benefits	2019-01-01	118
Total of all active and inactive participants	2019-01-01	291
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	291
Number of participants with account balances	2019-01-01	262
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	38
2018: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	294
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	266
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	47
Total of all active and inactive participants	2018-01-01	313
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	313
Number of participants with account balances	2018-01-01	253
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	25
2017: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	232
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	248
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	32
Total of all active and inactive participants	2017-01-01	280
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	280
Number of participants with account balances	2017-01-01	208
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	15
2016: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	414
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	199
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	21
Total of all active and inactive participants	2016-01-01	220
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	220
Number of participants with account balances	2016-01-01	161
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	14

Financial Data on INOVIO PHARMACEUTICALS, INC. 401(K) PLAN

Measure	Date	Value
2022 : INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$-613,825
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$4,020,090
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$3,929,347
Value of total corrective distributions	2022-12-31	$14,862
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$5,677,367
Value of total assets at end of year	2022-12-31	$31,385,710
Value of total assets at beginning of year	2022-12-31	$36,019,625
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$75,881
Total interest from all sources	2022-12-31	$14,659
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$2,000,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$3,876,375
Participant contributions at end of year	2022-12-31	$367,586
Participant contributions at beginning of year	2022-12-31	$258,414
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$24,630
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-4,633,915
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$31,385,710
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$36,019,625
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in pooled separate accounts at end of year	2022-12-31	$30,613,785
Value of interest in pooled separate accounts at beginning of year	2022-12-31	$34,934,965
Interest on participant loans	2022-12-31	$4,493
Interest earned on other investments	2022-12-31	$10,166
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2022-12-31	$404,339
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2022-12-31	$826,246
Net investment gain/loss from pooled separate accounts	2022-12-31	$-6,305,851
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$1,776,362
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$3,929,347
Contract administrator fees	2022-12-31	$75,881
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	MAYER HOFFMAN MCCANN P.C.
Accountancy firm EIN	2022-12-31	431947695
2021 : INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$10,107,754
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$3,171,187
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$3,144,700
Expenses. Certain deemed distributions of participant loans	2021-12-31	$0
Value of total corrective distributions	2021-12-31	$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$5,694,665
Value of total assets at end of year	2021-12-31	$36,019,625
Value of total assets at beginning of year	2021-12-31	$29,083,058
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$26,487
Total interest from all sources	2021-12-31	$21,606
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Administrative expenses professional fees incurred	2021-12-31	$0
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$2,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$3,397,415
Participant contributions at end of year	2021-12-31	$258,414
Participant contributions at beginning of year	2021-12-31	$238,149
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$783,841
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$6,936,567
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$36,019,625
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$29,083,058
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in pooled separate accounts at end of year	2021-12-31	$34,934,965
Value of interest in pooled separate accounts at beginning of year	2021-12-31	$26,971,483
Interest on participant loans	2021-12-31	$4,148
Interest earned on other investments	2021-12-31	$17,458
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2021-12-31	$826,246
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2021-12-31	$1,873,426
Expenses. Payments to insurance carriers foe the provision of benefits	2021-12-31	$0
Net investment gain/loss from pooled separate accounts	2021-12-31	$4,391,483
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$1,513,409
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$3,144,700
Contract administrator fees	2021-12-31	$26,487
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	MAYER HOFFMAN MCCANN P.C.
Accountancy firm EIN	2021-12-31	431947695
2020 : INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$8,271,405
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$1,846,561
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$1,841,084
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$4,463,812
Value of total assets at end of year	2020-12-31	$29,083,058
Value of total assets at beginning of year	2020-12-31	$22,658,214
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$5,477
Total interest from all sources	2020-12-31	$35,448
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$2,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$2,559,948
Participant contributions at end of year	2020-12-31	$238,149
Participant contributions at beginning of year	2020-12-31	$183,430
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$818,415
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$6,424,844
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$29,083,058
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$22,658,214
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in pooled separate accounts at end of year	2020-12-31	$26,971,483
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$21,464,165
Interest on participant loans	2020-12-31	$4,823
Interest earned on other investments	2020-12-31	$30,625
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2020-12-31	$1,873,426
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2020-12-31	$1,010,619
Net investment gain/loss from pooled separate accounts	2020-12-31	$3,772,145
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$1,085,449
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$1,841,084
Contract administrator fees	2020-12-31	$5,477
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Unqualified
Accountancy firm name	2020-12-31	MAYER HOFFMAN MCCANN P.C.
Accountancy firm EIN	2020-12-31	431947695
2019 : INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$7,899,280
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$1,863,900
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$1,859,652
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$3,829,114
Value of total assets at end of year	2019-12-31	$22,658,214
Value of total assets at beginning of year	2019-12-31	$16,622,834
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$4,248
Total interest from all sources	2019-12-31	$26,449
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$2,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$2,593,805
Participant contributions at end of year	2019-12-31	$183,430
Participant contributions at beginning of year	2019-12-31	$237,837
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$77,706
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$6,035,380
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$22,658,214
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$16,622,834
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in pooled separate accounts at end of year	2019-12-31	$21,464,165
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$15,458,418
Interest on participant loans	2019-12-31	$4,541
Interest earned on other investments	2019-12-31	$21,908
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2019-12-31	$1,010,619
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2019-12-31	$926,579
Net investment gain/loss from pooled separate accounts	2019-12-31	$4,043,717
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$1,157,603
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$1,859,652
Contract administrator fees	2019-12-31	$4,248
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	MAYER HOFFMAN MCCANN P.C.
Accountancy firm EIN	2019-12-31	431947695
2018 : INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$3,452,371
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$535,993
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$534,202
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$4,448,928
Value of total assets at end of year	2018-12-31	$16,622,834
Value of total assets at beginning of year	2018-12-31	$13,706,456
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$1,791
Total interest from all sources	2018-12-31	$21,553
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$2,200,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$2,502,270
Participant contributions at end of year	2018-12-31	$237,837
Participant contributions at beginning of year	2018-12-31	$308,627
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$786,338
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$2,916,378
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$16,622,834
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$13,706,456
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in pooled separate accounts at end of year	2018-12-31	$15,458,418
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$12,577,207
Interest on participant loans	2018-12-31	$5,302
Interest earned on other investments	2018-12-31	$16,251
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2018-12-31	$926,579
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2018-12-31	$820,622
Net investment gain/loss from pooled separate accounts	2018-12-31	$-1,018,110
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$1,160,320
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$534,202
Contract administrator fees	2018-12-31	$1,791
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	MAYER HOFFMAN MCCANN P.C.
Accountancy firm EIN	2018-12-31	431947695
2017 : INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$6,036,217
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$195,785
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$194,809
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$4,546,854
Value of total assets at end of year	2017-12-31	$13,706,456
Value of total assets at beginning of year	2017-12-31	$7,866,024
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$976
Total interest from all sources	2017-12-31	$18,121
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$2,200,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$1,942,558
Participant contributions at end of year	2017-12-31	$308,627
Participant contributions at beginning of year	2017-12-31	$192,694
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$1,732,386
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$5,840,432
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$13,706,456
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$7,866,024
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in pooled separate accounts at end of year	2017-12-31	$12,577,207
Value of interest in pooled separate accounts at beginning of year	2017-12-31	$6,909,666
Interest on participant loans	2017-12-31	$5,250
Interest earned on other investments	2017-12-31	$12,871
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2017-12-31	$820,622
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2017-12-31	$763,664
Net investment gain/loss from pooled separate accounts	2017-12-31	$1,471,242
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$871,910
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$194,809
Contract administrator fees	2017-12-31	$976
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	MAYER HOFFMAN MCCANN P.C.
Accountancy firm EIN	2017-12-31	431947695
2016 : INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$2,501,668
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$318,410
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$317,244
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$2,082,637
Value of total assets at end of year	2016-12-31	$7,866,024
Value of total assets at beginning of year	2016-12-31	$5,682,766
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$1,166
Total interest from all sources	2016-12-31	$17,566
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$200,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$1,164,457
Participant contributions at end of year	2016-12-31	$192,694
Participant contributions at beginning of year	2016-12-31	$129,387
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$421,561
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$2,183,258
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$7,866,024
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$5,682,766
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in pooled separate accounts at end of year	2016-12-31	$6,909,666
Value of interest in pooled separate accounts at beginning of year	2016-12-31	$4,944,038
Interest on participant loans	2016-12-31	$7,696
Interest earned on other investments	2016-12-31	$9,870
Value of funds held in insurance company general accounts (unallocated contracts) at end of year	2016-12-31	$763,664
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year	2016-12-31	$609,341
Net investment gain/loss from pooled separate accounts	2016-12-31	$401,465
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$496,619
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$317,244
Contract administrator fees	2016-12-31	$1,166
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	MAYER HOFFMAN MCCANN P.C.
Accountancy firm EIN	2016-12-31	431947695

Form 5500 Responses for INOVIO PHARMACEUTICALS, INC. 401(K) PLAN

2022: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	Yes
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Insurance	Yes
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement – Insurance	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Insurance	Yes
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement – Insurance	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: INOVIO PHARMACEUTICALS, INC. 401(K) PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Insurance	Yes
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement – Insurance	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

MINNESOTA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 66168 )

Policy contract number

067431

Policy instance

Insurance contract or identification number	067431
Number of Individuals Covered	377
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

MINNESOTA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 66168 )

Policy contract number

067431

Policy instance

Insurance contract or identification number	067431
Number of Individuals Covered	380
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

MINNESOTA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 66168 )

Policy contract number

067431

Policy instance

Insurance contract or identification number	067431
Number of Individuals Covered	333
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $0
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No

MINNESOTA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 66168 )

Policy contract number

067431

Policy instance

Insurance contract or identification number	067431
Number of Individuals Covered	291
Insurance policy start date	2019-01-01
Insurance policy end date	2019-12-31
Total amount of commissions paid to insurance broker	USD $32,857
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $32,857
Insurance broker organization code?	3

MINNESOTA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 66168 )

Policy contract number

067431

Policy instance

Insurance contract or identification number	067431
Number of Individuals Covered	313
Insurance policy start date	2018-01-01
Insurance policy end date	2018-12-31
Total amount of commissions paid to insurance broker	USD $39,456
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $39,456
Insurance broker organization code?	3

MINNESOTA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 66168 )

Policy contract number

067431

Policy instance

Insurance contract or identification number	067431
Number of Individuals Covered	280
Insurance policy start date	2017-01-01
Insurance policy end date	2017-12-31
Total amount of commissions paid to insurance broker	USD $28,874
Total amount of fees paid to insurance company	USD $0
Are there contracts with allocated funds for individual policies?	0
Are there contracts with allocated funds for group deferred annuity?	No
Are there contracts with allocated funds for types other than group deferred annuity or individual?	No
Contract purchased, in whole or in part, to distribute benefits from a terminating plan	No
Contracts With Unallocated Funds Deposit Administration	0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?	No
Are there contracts with unallocated funds for contracts of type guaranteed investment?	No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?	Yes
Health Insurance Welfare Benefit	No
Dental Insurance Welfare Benefit	No
Vision Insurance Welfare Benefit	No
Life Insurance Welfare Benefit	No
Temporary Disability Insurance Welfare Benefit	No
Long Term Disability Insurance Welfare Benefit	No
Unemployment Insurance Welfare Benefit	No
Were dividends or retroactive rate refunds paid in cash?	No
Were dividends or retroactive rate refunds paid as a credit?	No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $28,874
Insurance broker organization code?	3
Insurance broker name	WADDELL AND REED INC

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	INOVIO PHARMACEUTICALS, INC.
Employer identification number (EIN):	330969592
NAIC Classification:	541700